TASSINARI, ELISA

TASSINARI, ELISA  

Borsisti  

Mostra records
Risultati 1 - 20 di 23 (tempo di esecuzione: 0.064 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A prospective study on the early evaluation of response to androgen receptor-targeted agents with 11C-Choline, 68Ga-PSMA, and 18F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experience Mollica, V.; Marchetti, A.; Fraccascia, N.; Nanni, C.; Tabacchi, E.; Malizia, C.; Argalia, G.; Ro...sellini, M.; Tassinari, E.; Paccapelo, A.; Fanti, S.; Massari, F. 2024-01-01 ESMO OPEN - 1.01 Articolo in rivista -
Appropriateness of Mini-Invasive Approaches for Nausea and Vomiting Refractory to Medical Therapy in Palliative Care Setting: A Case Report Casadio, Chiara; Tassinari, Elisa; Carloni, Riccardo; Rossi, Romina; Tenti, Maria Valentina; Fabb...ri, Laura; Maltoni, Marco 2024-01-01 CASE REPORTS IN ONCOLOGY - 1.01 Articolo in rivista 000536218.pdfSupplementary_material-Suppl.1-s1.pdf
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis Rosellini, Matteo; Mollica, Veronica; Marchetti, Andrea; Coluccelli, Sara; Giunchi, Francesca; Ta...ssinari, Elisa; Ricci, Costantino; Fiorentino, Michelangelo; Tallini, Giovanni; De Biase, Dario; Massari, Francesco 2024-01-01 PATHOLOGY, RESEARCH AND PRACTICE - 1.01 Articolo in rivista -
Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma Mollica, Veronica; Rosellini, Matteo; Brocchi, Stefano; Galuppi, Francesco; Paccapelo, Alexandro;... Tateo, Valentina; Marchetti, Andrea; Tassinari, Elisa; Mantuano, Francesco; Santoni, Matteo; Massari, Francesco 2024-01-01 EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT - 1.01 Articolo in rivista ERPMDD 2024 [TGR].pdf
What is the risk of hepatotoxicity induced by immune-checkpoint inhibitors and how can we avoid it? Tassinari, Elisa; Rosellini, Matteo; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco 2024-01-01 EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY - 1.01 Articolo in rivista -
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Tateo, Valentina; Nuvola, Giacomo; Rizzo,... Alessandro; Massari, Francesco; Mollica, Veronica 2023-01-01 EXPERT OPINION ON DRUG SAFETY - 1.01 Articolo in rivista -
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis Santoni, Matteo; Rizzo, Alessandro; Kucharz, Jakub; Mollica, Veronica; Rosellini, Matteo; Marchet...ti, Andrea; Tassinari, Elisa; Monteiro, Fernando Sabino Marques; Soares, Andrey; Molina-Cerrillo, Javier; Grande, Enrique; Battelli, Nicola; Massari, Francesco 2023-01-01 CANCER IMMUNOLOGY, IMMUNOTHERAPY - 1.01 Articolo in rivista -
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma? Conci, Nicole; Tassinari, Elisa; Tateo, Valentina; Rosellini, Matteo; Marchetti, Andrea; Ricci, C...ostantino; Chessa, Francesco; Santoni, Matteo; Grande, Enrique; Mollica, Veronica; Massari, Francesco 2023-01-01 MOLECULAR DIAGNOSIS & THERAPY - 1.01 Articolo in rivista Molecular Diagn Ther 2023 [Neoadj UC].pdf
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study Rizzo, Alessandro; Mollica, Veronica; Tateo, Valentina; Tassinari, Elisa; Marchetti, Andrea; Rose...llini, Matteo; De Luca, Raffaele; Santoni, Matteo; Massari, Francesco 2023-01-01 CANCER IMMUNOLOGY, IMMUNOTHERAPY - 1.01 Articolo in rivista -
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis Rizzo, Alessandro; Nuvola, Giacomo; Palmiotti, Gennaro; Ahcene-Djaballah, Selma; Mollica, Veronic...a; Rosellini, Matteo; Marchetti, Andrea; Nigro, Maria Concetta; Tassinari, Elisa; Macrini, Sveva; Massari, Francesco 2023-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report Elisa Tassinari, Nicole Conci, Giacomo Battisti, Francesco Porta, Valerio Di Scioscio, Maria Giul...ia Pirini, Dario de Biase, Maria Concetta Nigro, Miriam Iezza, Fausto Castagnetti, Luigi Lovato, Stefano Fanti, Maria Abbondanza Pantaleo, Margherita Nannini 2023-01-01 FRONTIERS IN ONCOLOGY - 1.01 Articolo in rivista Tassinari, Conci Front Oncol 2023.pdf
Prostate cancer and novel pharmacological treatment options - what's new for 2022? Marchetti, Andrea; Tassinari, Elisa; Rosellini, Matteo; Rizzo, Alessandro; Massari, Francesco; Mo...llica, Veronica 2023-01-01 EXPERT REVIEW OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista -
Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients with Renal Cell Carcinoma After Progression with Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised, Open-label, Phase 3 Trial Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Mollica, Veronica; Massari, Francesco 2023-01-01 EUROPEAN UROLOGY - 1.01 Articolo in rivista -
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab Mollica, Veronica; Tassinari, Elisa; Santoni, Matteo; Marchese, Paola Valeria; Giunchi, Francesca...; Maloberti, Thais; Tateo, Valentina; Ricci, Costantino; Rosellini, Matteo; Marchetti, Andrea; Fiorentino, Michelangelo; Biase, Dario De; Massari, Francesco 2023-01-01 PATHOLOGY RESEARCH AND PRACTICE - 1.01 Articolo in rivista -
The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study Mollica, Veronica; Rizzo, Alessandro; Marchetti, Andrea; Tateo, Valentina; Tassinari, Elisa; Rose...llini, Matteo; Massafra, Raffaella; Santoni, Matteo; Massari, Francesco 2023-01-01 CLINICAL AND EXPERIMENTAL MEDICINE - 1.01 Articolo in rivista Clin Exp Med. 2023 [MOUSEION 06].pdf
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy Marchese, Paola Valeria; Mollica, Veronica; De Biase, Dario; Giunchi, Francesca; Tassinari, Elisa...; Marchetti, Andrea; Rosellini, Matteo; Nuvola, Giacomo; Maloberti, Thais; Fiorentino, Michelangelo; Massari, Francesco 2022-01-01 PATHOLOGY RESEARCH AND PRACTICE - 1.01 Articolo in rivista -
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study Rizzo A.; Mollica V.; Marchetti A.; Nuvola G.; Rosellini M.; Tassinari E.; Molina-Cerrillo J.; My...int Z.W.; Buchler T.; Monteiro F.S.M.; Grande E.; Santoni M.; Massari F. 2022-01-01 CANCERS - 1.01 Articolo in rivista Cancers 2022 [MOUSEION04].pdfcancers-14-04142-s001.zip
Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw Mollica V.; Nuvola G.; Tassinari E.; Nigro M.C.; Marchetti A.; Rosellini M.; Rizzo A.; Errani C.;... Massari F. 2022-01-01 CURRENT ONCOLOGY - 1.01 Articolo in rivista Current Oncology 2022 [Bone agents PCa].pdf
Guiding treatment selection with immunotherapy compared to targeted therapy agents in patients with metastatic kidney cancer Rosellini M.; Marchetti A.; Tassinari E.; Nuvola G.; Rizzo A.; Santoni M.; Mollica V.; Massari F. 2022-01-01 EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT - 1.01 Articolo in rivista -
Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers Marchese P.V.; Mollica V.; Tassinari E.; De Biase D.; Giunchi F.; Marchetti A.; Rosellini M.; Fio...rentino M.; Massari F. 2022-01-01 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS - 1.01 Articolo in rivista -